Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This studay evaluates the effect of the glucagon‐like peptide‐1 (GLP‐1) receptor agonist,including Liraglutide,Exenatide and Exenatide Microspheres for Injection,in the treatment of subjects who are overweight or obese.
Epistemonikos ID: 94d9c02170b3f136bc2872b7c6b39a6e70dea832
First added on: May 21, 2024